Sutro Biopharma
STRO
$3.99
Share price
6.68%
Change (1 day)
-12.88%
Change (1 year)
Categories
Sutro Biopharma (STRO) - P/B ratio
P/B ratio as of May 2024 : 1.92
According to Sutro Biopharma's latest financial reports the company has a price-to-book ratio of 1.92.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sutro Biopharma - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.75 | -18.33% |
| 2022-12-31 | 2.14 | -21.61% |
| 2021-12-31 | 2.73 | -8.76% |
| 2020-12-31 | 2.99 | 15.13% |
| 2019-12-31 | 2.60 | 65.84% |
| 2018-12-31 | 1.57 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6372 | -66.85% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | 1.90% | 🇺🇸 USA |